Drugs / ClinOleic 20%®
ClinOleic 20%®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00600912 Comparator | Dec 2006 → Dec 2007 | inflammatory disease | Klinikum Ludwigshafen | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ClinOleic 20% | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00600912 ↗ |
| Known as | ClinOleic 20% (Baxter Deutschland GmbH,Unterschleissheim, Germany) | “ClinOleic 20%® (Baxter Deutschland GmbH,Unterschleissheim, Germany)” NCT00600912 ↗ |
| Modality | Other / unclassified | “a lipid emulsion based on olive and soybean oil” NCT00600912 ↗ |